In order to ascertain how the guidance is used and the relevance of individual studies to current drug development portfolios, the Safety Pharmacology Society and NC3Rs have generated a short survey to gather high-level information on the opinions of individual scientists into the scope for revis...
The Safety Pharmacology Society (SPS) invites you to participate in their survey titled “Gastrointestinal (GI) Testing in Drug Development.”
We would appreciate you taking a few minutes to complete this brief survey about the scientific topics you wish to learn more about. Your input will assist in the planning for future meetings.
The Safety Pharmacology Society (SPS) Best Practice Committee invites you to participate in their survey titled “Experimental Design and Data Analysis in Cardiovascular Safety Pharmacology Studies.”
Your voice is an important part of our future direction and we appreciate the time you are investing to help us with this collaborative effort.